Showing results (661-670 of 718) with videos related to

Sort By:
Pageof 72
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2017
NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapyHiroshi Nakanishi, Yoshiyuki Kawashima, Kiyoto Kurima, et al.
Nature Structural & Molecular Biology|May 9, 2024
Computational design of non-porous pH-responsive antibody nanoparticlesErin C Yang, Robby Divine, Marcos C Miranda, et al.
The Journal of Clinical Investigation|March 15, 2022
Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotypeYounglang Lee, Alex W Wessel, Jiazhi Xu, et al.
Nature Genetics|September 15, 2014
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndromeScott W Canna, Adriana A de Jesus, Sushanth Gouni, et al.
Frontiers in Immunology|April 5, 2021
Spectrum of Systemic Auto-Inflammatory Diseases in India: A Multi-Centric ExperienceDeepti Suri, Amit Rawat, Ankur Kumar Jindal, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitorsXiaocong M Ye, Andrei W Konradi, Minghua Sun, et al.
Journal of the American Academy of Dermatology|April 15, 2025
Skincare ingredients recommended by cosmetic dermatologists: A Delphi consensus studyGabriella V Alvarez, Bianca Y Kang, Alexandra M Richmond, et al.
American Journal of Human Genetics|April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasisCatherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 23, 2022
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patientsMarcos J Ramos-Benitez, Jeffrey R Strich, Sara Alehashemi, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2009
Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline gamma-secretase inhibitorsAnh P Truong, Danielle L Aubele, Gary D Probst, et al.
Pageof 72